{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:16:38Z","timestamp":1788264998848,"version":"build-2803163510"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Ultrasound is a standard tool to diagnose giant cell arteritis (GCA). Until now, only a few studies have investigated the role of ultrasound in the follow-up of GCA. The aim of this study was to assess the changes in the intima\u2013media thickness (IMT), total number of affected arteries and provisional OMERACT GCA ultrasonography score (OGUS) in a 12-months follow-up period.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with newly diagnosed GCA were prospectively enrolled. Ultrasound examinations of facial, temporal, carotid, vertebral and axillary arteries were performed at baseline, after 3, 6, 9 and 12\u2009months. Changes of IMT, total number of affected arteries and OGUS values were evaluated. In a subgroup of patients, exams were conducted weekly in the first 100\u2009days.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Fifty patients were enrolled and 36 completed the follow-up. Significant reductions in IMT, total number of affected arteries and OGUS were observed. Eighteen patients presented to weekly exams. The mean IMT of the axillary artery normalized after 7\u2009days, while IMT of the common temporal artery normalized after 50\u2009days. The mean OGUS values were below 1 after 6\u2009months. There were no differences in IMT changes between GCA patients with or without PMR or between those with and without additional tocilizumab treatment. A relapse occurred in four patients. At relapse, mean IMT and OGUS were higher as compared to the preceding assessment. No predictive values indicating a relapse were identified.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Vascular ultrasound is sensitive to change in GCA. The presence of PMR or treatment with tocilizumab did not affect IMT decrease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae098","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T07:03:15Z","timestamp":1708153395000},"page":"732-739","source":"Crossref","is-referenced-by-count":11,"title":["Follow-up ultrasound examination in patients with newly diagnosed giant cell arteritis"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6591-5936","authenticated-orcid":false,"given":"Valentin S","family":"Sch\u00e4fer","sequence":"first","affiliation":[{"name":"Clinic of Internal Medicine III, Department of Oncology, Haematology, Rheumatology and Clinical Immunology, University Hospital Bonn , Bonn,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0173-0668","authenticated-orcid":false,"given":"Christian","family":"Dejaco","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Medical University of Graz , Graz,","place":["Austria"]},{"name":"Department of Rheumatology, Hospital of Bruneck (ASAA-SABES), Teaching Hospital of the Paracelsus Medical University , Bruneck,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Karakostas","sequence":"additional","affiliation":[{"name":"Clinic of Internal Medicine III, Department of Oncology, Haematology, Rheumatology and Clinical Immunology, University Hospital Bonn , Bonn,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Behning","sequence":"additional","affiliation":[{"name":"Institute of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn , Bonn,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Brossart","sequence":"additional","affiliation":[{"name":"Clinic of Internal Medicine III, Department of Oncology, Haematology, Rheumatology and Clinical Immunology, University Hospital Bonn , Bonn,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5379-9149","authenticated-orcid":false,"given":"Lara C","family":"Burg","sequence":"additional","affiliation":[{"name":"Clinic of Internal Medicine III, Department of Oncology, Haematology, Rheumatology and Clinical Immunology, University Hospital Bonn , Bonn,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"key":"2025032905213303900_keae098-B1","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2017.142","article-title":"Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities","volume":"13","author":"Dejaco","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"2025032905213303900_keae098-B2","first-page":"137","article-title":"Management guidelines and outcome measures in giant cell arteritis (GCA)","volume":"25","author":"Warrington","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"2025032905213303900_keae098-B3","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.semarthrit.2011.10.005","article-title":"Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis","volume":"41","author":"Kermani","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"2025032905213303900_keae098-B4","doi-asserted-by":"crossref","first-page":"iii5","DOI":"10.1093\/rheumatology\/kez553","article-title":"Diagnosis of giant cell arteritis","volume":"59","author":"Ponte","year":"2020","journal-title":"Rheumatology"},{"key":"2025032905213303900_keae098-B5","first-page":"901795","article-title":"Tongue necrosis as an initial manifestation of giant cell arteritis: case report and review of the literature","volume":"2015","author":"Zaragoza","year":"2015","journal-title":"Case Rep Rheumatol"},{"key":"2025032905213303900_keae098-B6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/1573397115666190227194014","article-title":"Giant Cell Arteritis (GCA): pathogenesis, clinical aspects and treatment approaches","volume":"15","author":"Ciofalo","year":"2019","journal-title":"Curr Rheumatol Rev"},{"key":"2025032905213303900_keae098-B7","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2025032905213303900_keae098-B8","doi-asserted-by":"crossref","first-page":"e000598","DOI":"10.1136\/rmdopen-2017-000598","article-title":"Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group","volume":"4","author":"Chrysidis","year":"2018","journal-title":"RMD Open"},{"key":"2025032905213303900_keae098-B9","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/annrheumdis-2021-220306","article-title":"Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: a prospective analysis","volume":"80","author":"Ponte","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2025032905213303900_keae098-B10","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/rheumatology\/kex143","article-title":"Ultrasound cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis","volume":"56","author":"Sch\u00e4fer","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2025032905213303900_keae098-B11","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/rheumatology\/keaa578","article-title":"The cut-off values for the intima-media complex thickness assessed by colour Doppler sonography in seven cranial and aortic arch arteries","volume":"60","author":"Je\u0161e","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025032905213303900_keae098-B12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/ard-2022-223367","article-title":"The provisional OMERACT ultrasonography score for giant cell arteritis","volume":"82","author":"Dejaco","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025032905213303900_keae098-B13","first-page":"107","article-title":"Follow-up vascular ultrasounds in patients with giant cell arteritis","volume":"38(Suppl 124)","author":"Ford","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"2025032905213303900_keae098-B14","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1093\/rheumatology\/keab179","article-title":"Ultrasonography in the diagnosis and follow-up of giant cell arteritis","volume":"60","author":"Coath","year":"2021","journal-title":"Rheumatology"},{"key":"2025032905213303900_keae098-B15","doi-asserted-by":"crossref","first-page":"1759720X21998505","DOI":"10.1177\/1759720X21998505","article-title":"Ultrasound for diagnosis and follow-up of chronic axillary vasculitis in patients with long-standing giant cell arteritis","volume":"13","author":"Bosch","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2025032905213303900_keae098-B16","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/ard-2022-223480","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"81","author":"Ponte","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025032905213303900_keae098-B17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.semarthrit.2016.11.002","article-title":"Newly diagnosed vs. relapsing giant cell arteritis: baseline data from the GiACTA trial","volume":"46","author":"Tuckwell","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2025032905213303900_keae098-B18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/rheumatology\/kem322","article-title":"Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis","volume":"47","author":"Schmidt","year":"2008","journal-title":"Rheumatology"},{"key":"2025032905213303900_keae098-B19","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/rheumatology\/key383","article-title":"Vessel wall plasticity in large vessel giant cell arteritis: an ultrasound follow-up study","volume":"58","author":"Aschwanden","year":"2019","journal-title":"Rheumatology"},{"key":"2025032905213303900_keae098-B20","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1093\/rheumatology\/keab484","article-title":"Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritis","volume":"60","author":"Seitz","year":"2021","journal-title":"Rheumatology"},{"key":"2025032905213303900_keae098-B21","doi-asserted-by":"crossref","first-page":"e000612","DOI":"10.1136\/rmdopen-2017-000612","article-title":"Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations","volume":"4","author":"Duftner","year":"2018","journal-title":"RMD Open"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae098\/56808401\/keae098.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/2\/732\/56808401\/keae098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/2\/732\/56808401\/keae098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T03:38:08Z","timestamp":1743392288000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/2\/732\/7609047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,15]]},"published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae098","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,2,15]]}}}